GB202107261D0 - Treatment of severe to critical covid - Google Patents

Treatment of severe to critical covid

Info

Publication number
GB202107261D0
GB202107261D0 GBGB2107261.6A GB202107261A GB202107261D0 GB 202107261 D0 GB202107261 D0 GB 202107261D0 GB 202107261 A GB202107261 A GB 202107261A GB 202107261 D0 GB202107261 D0 GB 202107261D0
Authority
GB
United Kingdom
Prior art keywords
severe
treatment
critical covid
covid
critical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2107261.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Precisemed Ltd
Original Assignee
Precisemed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Precisemed Ltd filed Critical Precisemed Ltd
Priority to GBGB2107261.6A priority Critical patent/GB202107261D0/en
Publication of GB202107261D0 publication Critical patent/GB202107261D0/en
Ceased legal-status Critical Current

Links

GBGB2107261.6A 2021-05-20 2021-05-20 Treatment of severe to critical covid Ceased GB202107261D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2107261.6A GB202107261D0 (en) 2021-05-20 2021-05-20 Treatment of severe to critical covid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2107261.6A GB202107261D0 (en) 2021-05-20 2021-05-20 Treatment of severe to critical covid

Publications (1)

Publication Number Publication Date
GB202107261D0 true GB202107261D0 (en) 2021-07-07

Family

ID=76637690

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2107261.6A Ceased GB202107261D0 (en) 2021-05-20 2021-05-20 Treatment of severe to critical covid

Country Status (1)

Country Link
GB (1) GB202107261D0 (en)

Similar Documents

Publication Publication Date Title
IL275321A (en) Compounds for treatment of diseases related to dux4 expression
EP4132507A4 (en) Methods of treatment of coronavirus-induced inflammation conditions
GB202006665D0 (en) Treatment of ischaemia
EP4096703A4 (en) Therapeutic uses of tirzepatide
IL282311A (en) Use of reboxetine to treat narcolepsy
GB202107261D0 (en) Treatment of severe to critical covid
GB2595513B (en) Treatment of infections
GB202102257D0 (en) Treatment of shells
EP4114396A4 (en) Methods of administering elagolix
GB201907305D0 (en) Treatment of conditions
GB202101251D0 (en) Treatment of conditions
GB202307686D0 (en) Treatment of conditions
GB202315695D0 (en) TReatment of cariomyopathy
GB202001353D0 (en) Treatment of skin conditions
GB202012880D0 (en) Treatment of ischemia
GB202118011D0 (en) Methods of treatment
GB202118007D0 (en) Methods of treatment
GB202118006D0 (en) Methods of treatment
GB202108242D0 (en) Methods of treatment
GB202108245D0 (en) Methods of treatment
GB202005874D0 (en) Methods of treatment
ZA202005856B (en) Treatment of infections
GB202010631D0 (en) Treatment of baterical vaginosis
GB202109534D0 (en) Treatment of scarring
GB202201825D0 (en) Methods of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)